Germany: patient liable to pay quarterly fee:
This article was originally published in Clinica
Executive Summary
The social court Dusseldorf has ruled in a test case that a patient is liable to pay the E10 ($12.80) quarterly GPs fee, the Praxisgebuhr. The individual had claimed in court that the local sickness fund, KV Nordrhein, should pay the fee, given his salary of E1,000 per month. The Praxisgebuhr was brought in under the German health reforms of 2004. Patients must pay the fee on the first visit only to their doctor every quarter. The case, heard on March 22, ruled that there was no legal basis for these fees to be paid by the sickness funds.
You may also be interested in...
US FDA Drugs Center Ready To Break Down Silos On Regulatory Innovation
CDER Director Cavazzoni is promising to increase coordination and collaboration to accelerate broader adoption of innovative clinical trial designs and other approaches to speed drug development. A new "Quantitative Medicine Center of Excellence" illustrates the approach.
New OSP Director To Guide CDER-Wide IT Upgrades; System Enhancements Speed ANDA Assessments
Generic Drug Structured Assessment for Bioequivalence launched in 2023 and has been used in 40 ANDA reviews so far.
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.